Cannabis as a painkiller – is it a miracle cure or an overrated drug? This Swiss documentary provides an in-depth look at pharmacy production, patient cases, the legal situation and medical reality. Between euphoria and disillusionment, cannabis meets both hope and skepticism. Discover more about cannabis as medicine here : Diseases.
Cannabis in the pharmacy: THC oil, tincture & special formulations
In Manfred Fankhauser ‘s Emmental pharmacy (documentary below), cannabis is not treated as a “lifestyle product”, but is processed pharmaceutically. He has been fighting for medicinal cannabis for over 30 years – and was the first Swiss person to obtain an official manufacturing license. THC is diluted there, bottled as an oil or mixed as a tincture. The aim: medicine instead of a joint.
- Pure THC stored in the vault
- Oil & tincture for pain patients
- Individual extemporaneous preparations
Patient reports: When cannabis changes pain
A key example in the documentary is Franziska Quadri. Quadriplegia, chronic pain, muscle spasms – it was cannabis that brought her relief. She reduced her medication, found better sleep and quality of life. In Spain, she uses social clubs, receives a choice of varieties, capsules and a constant supply. Her sentence sticks: “Cannabis was actually the solution to the problem.”
- Pain patient → strong improvement
- Choice of variety & dosage decisive
- Spain easier than Switzerland
The scientific mirror: Does cannabis really work?
Despite field reports, the study situation remains thin. Research shows that cannabis is sometimes effective for chronic nerve pain, loss of appetite, spasticity – especially in MS(field report) and chemotherapy. However, there are many cases with no effect, such as pain patient Nicolas. The effect depends on the dosage, combination of active ingredients, clinical picture and individual reaction.
- Partially effective for nerve pain
- Useful against loss of appetite
- Contradictory study data
Endocannabinoid system: Why cannabis works in the body
Our body produces cannabinoids itself. They regulate pain, inflammation, appetite, immune response and stress(cortisol). Cannabis docks there – theoretically logical, practically complex. Not all receptors have been researched yet, mechanisms of action remain open. But: patient successes are driving research forward. Learn more about the endocannabinoid system here.
- Endogenous cannabinoids
- Regulation → Pain, appetite, stress
- Still many unanswered questions
Costs, access & law – why many are still not supplied
Prescribable in future like any anaesthetic – but it remains expensive. Patients speak of CHF 800-2,000/month, depending on need. Many doctors feel insecure, bureaucratic hurdles remain. Those who are not fully treated → do not get a prescription. Many therefore procure illegally or via social clubs.
- Very high treatment costs
- Medical uncertainty when prescribing
- Many turn to the black market/social clubs
Conclusion? Hope, reality or middle ground?
Cannabis is neither a miracle cure nor a zero effect. There is a broad spectrum between successes like Franziska and zero effect like Nicolas. Research is catching up, the law is making access easier – but costs, quality assurance and knowledge in the healthcare system will determine how important cannabis really becomes in the future.
- Life-changing for some
- Ineffective for some
- Access is getting easier – not cheap
